GHK-Cu Dosage Guide: Injection, Topical & Protocol
Educational reference for GHK-Cu (copper peptide) dosage protocols including subcutaneous injection, topical application, and microneedling as discussed in published research.
Medical Disclaimer
This guide is for educational and informational purposes only. It is not medical advice. Dosages described reflect ranges discussed in published research and clinical practice literature — they are not recommendations. Always consult a licensed healthcare provider before using any peptide. Legality and availability vary by jurisdiction.
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide first identified in human plasma. Research has demonstrated its involvement in wound healing, tissue remodeling, collagen synthesis, and anti-inflammatory signaling. The peptide is found endogenously at approximately 200 ng/mL in plasma at age 20, declining to roughly 80 ng/mL by age 60, which has prompted interest in supplementation. GHK-Cu has been studied in both injectable and topical formats, with topical copper peptide serums being widely available in the skincare market. The following dosage information is compiled from research literature for educational reference only.
Dosing Protocols
Subcutaneous Injection Protocol
Discussed in research contexts for systemic wound healing and anti-aging effects. Start at the lower end of the range to assess individual tolerance. Inject into fatty tissue (abdomen, thigh). Rotate injection sites.
Topical Serum Application
Apply to clean, dry skin. Commonly used on the face, neck, and hands. Research by Pickart et al. has documented improvements in skin thickness, elasticity, and firmness with regular topical application of copper peptides.
Microneedling Combination Protocol
Microneedling creates microchannels that enhance peptide absorption into the dermis. Apply GHK-Cu serum immediately after the microneedling procedure. This approach has been discussed in dermatological literature for scar remodeling and skin rejuvenation.
Reconstitution & Storage
| Vial sizes | 50 mg lyophilized powder per vial (injectable format) |
| Recommended water volume | 2 mL bacteriostatic water (BAC water) |
| Storage | Store unreconstituted vials at 2–8 °C (36–46 °F). Protect from light. |
| Stability once reconstituted | Reconstituted solution is generally stable for up to 30 days when refrigerated. Copper peptide solutions may develop a blue tint, which is normal and indicates the copper complex is intact. |
Use our reconstitution calculator to determine exact syringe units for your dose.
Cycle Guidance
For injectable protocols, cycles of 4–8 weeks followed by a similar off period are commonly discussed. Topical application can generally be used on an ongoing basis, as systemic absorption from topical copper peptides is minimal. Research has not established firm cycling requirements, but periodic breaks from injectable use are often recommended in community protocols.
Stacking Considerations
- Frequently discussed alongside BPC-157 for enhanced tissue repair and wound healing, as the two peptides may act through complementary pathways.
- Topical GHK-Cu is often combined with retinoids (with separate application times — retinoid at night, GHK-Cu in morning) in skincare protocols.
- May be used concurrently with TB-500 for recovery-focused stacks, though clinical evidence for this combination is absent.
- Avoid combining topical GHK-Cu with strong acids (AHAs, BHAs at high concentrations) in the same application, as low pH may destabilize the copper complex.
Potential Side Effects
- Injection site irritation, redness, or mild swelling
- Skin flushing (transient, typically mild)
- Mild headache reported in some users of injectable protocols
- Contact dermatitis from topical application (uncommon; patch test recommended)
- Theoretical copper accumulation with prolonged high-dose injectable use
- Nausea at higher injectable doses (rare)
Contraindications & Cautions
- Known allergy or hypersensitivity to copper or any component of the formulation
- Wilson disease or other copper metabolism disorders — exogenous copper may exacerbate copper overload
- Active skin infections at the intended topical application or injection site
- Pregnancy and breastfeeding — insufficient safety data
- Individuals with hepatic impairment should exercise caution due to copper metabolism through the liver
Related
References
- The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health (2008) — PubMed
- GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration (2015) — PubMed
- GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes (2020) — PubMed
- Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data (2018)